Working Group 5
WG5. Clinical Treatment Recommendation
Advancing radiotherapy through radiomics and multimodal -omics, refining pathological grading and personalising treatment for low- and high-risk patients.
WG5
Objectives
Clinical Treatment Recommendations (Theme 5) develops new therapeutic approaches in radiotherapy by combining radiomics and multimodal -omics, enabling a Wait-and-See strategy for low-risk-of-growth patients and timely personalised intervention for high-risk cases.
- Objectives. To improve patient outcomes through personalised medicine research. Relevant to RCO5, RCO4 and RCO3.
- Tasks. T5.1 Improve state-of-the-art and good practices in RT optimisation; T5.2 Establish a network of clinicians leading investigator-initiated trials in brain tumours; T5.3 WG5 meetings.
- Activities. Involved in all MC and WG5 meetings, co-organisation of a WG4/WG5-focused conference, contributions to annual and final reports and the final-year conference, two peer-reviewed joint publications, and dissemination, training schools.
- Milestones. M5.1 Mid-term report — Month 25; M5.2 WG4/WG5 conference — Month 34.
Coordination
Contact the leaderContact the working group
Work with this group's leader to join meetings, contribute activities, or propose training and events.
Join Working Group 5
Working groups welcome active contributions from Action members. Contact the WG leader to get involved.